Literature DB >> 22968455

CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells.

Niklas K Björkström1, Vivien Béziat, Frank Cichocki, Lisa L Liu, Jeffrey Levine, Stella Larsson, Richard A Koup, Stephen K Anderson, Hans-Gustaf Ljunggren, Karl-Johan Malmberg.   

Abstract

Epistatic interactions between killer cell immunoglobulin-like receptors (KIRs) and their cognate HLA class I ligands have important implications for reproductive success, antiviral immunity, susceptibility to autoimmune conditions and cancer, as well as for graft-versus-leukemia reactions in settings of allogeneic stem cell transplantation. Although CD8 T cells are known to acquire KIRs when maturing from naive to terminally differentiated cells, little information is available about the constitution of KIR repertoires on human CD8 T cells. Here, we have performed a high-resolution analysis of KIR expression on CD8 T cells. The results show that most CD8 T cells possess a restricted KIR expression pattern, often dominated by a single activating or inhibitory KIR. Furthermore, the expression of KIR, and its modulation of CD8 T-cell function, was independent of expression of self-HLA class I ligands. Finally, despite similarities in the stochastic regulation of KIRs by the bidirectional proximal promoter, the specificity of inhibitory KIRs on CD8 T cells was often distinct from that of natural killer cells in the same individual. The results provide new insight into the formation of KIR repertoires on human T cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22968455      PMCID: PMC3482857          DOI: 10.1182/blood-2012-03-416867

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

Review 1.  MHC class I molecules and KIRs in human history, health and survival.

Authors:  Peter Parham
Journal:  Nat Rev Immunol       Date:  2005-03       Impact factor: 53.106

2.  Uncoupling of T-cell effector functions by inhibitory killer immunoglobulin-like receptors.

Authors:  Gabriella Henel; Karnail Singh; Dapeng Cui; Sergey Pryshchep; Won-Woo Lee; Cornelia M Weyand; Jörg J Goronzy
Journal:  Blood       Date:  2006-02-09       Impact factor: 22.113

3.  Distinct transcriptional control mechanisms of killer immunoglobulin-like receptors in natural killer (NK) and in T cells.

Authors:  Jing Xu; Abbe N Vallejo; Yong Jiang; Cornelia M Weyand; Jörg J Goronzy
Journal:  J Biol Chem       Date:  2005-04-29       Impact factor: 5.157

4.  MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response.

Authors:  Makoto Yawata; Nobuyo Yawata; Monia Draghi; Fotini Partheniou; Ann-Margaret Little; Peter Parham
Journal:  Blood       Date:  2008-06-26       Impact factor: 22.113

5.  Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection.

Authors:  Niklas K Björkström; Veronica D Gonzalez; Karl-Johan Malmberg; Karolin Falconer; Annette Alaeus; Greg Nowak; Carl Jorns; Bo-Göran Ericzon; Ola Weiland; Johan K Sandberg; Hans-Gustaf Ljunggren
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

6.  Ligand-independent exhaustion of killer immunoglobulin-like receptor-positive CD8+ T cells in human immunodeficiency virus type 1 infection.

Authors:  Galit Alter; Suzannah Rihn; Hendrik Streeck; Nickolas Teigen; Alicja Piechocka-Trocha; Kristin Moss; Kristen Cohen; Angela Meier; Florencia Pereyra; Bruce Walker; Marcus Altfeld
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

7.  A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature.

Authors:  Sarah Cooley; Feng Xiao; Michelle Pitt; Michelle Gleason; Valarie McCullar; Tracy L Bergemann; Karina L McQueen; Lisbeth A Guethlein; Peter Parham; Jeffrey S Miller
Journal:  Blood       Date:  2007-03-28       Impact factor: 22.113

8.  Features and distribution of CD8 T cells with human leukocyte antigen class I-specific receptor expression in chronic hepatitis C.

Authors:  Paula Bonorino; Vincent Leroy; Tania Dufeu-Duchesne; Stefania Tongiani-Dashan; Nathalie Sturm; Martine Pernollet; Eric Vivier; Jean-Pierre Zarski; Patrice N Marche; Evelyne Jouvin-Marche
Journal:  Hepatology       Date:  2007-11       Impact factor: 17.425

9.  Reprogramming of CTLs into natural killer-like cells in celiac disease.

Authors:  Bertrand Meresse; Shane A Curran; Cezary Ciszewski; Gerasim Orbelyan; Mala Setty; Govind Bhagat; Leanne Lee; Maria Tretiakova; Carol Semrad; Emily Kistner; Robert J Winchester; Veronique Braud; Lewis L Lanier; Daniel E Geraghty; Peter H Green; Stefano Guandalini; Bana Jabri
Journal:  J Exp Med       Date:  2006-05-08       Impact factor: 14.307

Review 10.  Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections.

Authors:  Janko Nikolich-Zugich
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

View more
  46 in total

1.  Dengue-specific CD8+ T cell subsets display specialized transcriptomic and TCR profiles.

Authors:  Yuan Tian; Mariana Babor; Jerome Lane; Grégory Seumois; Shu Liang; N D Suraj Goonawardhana; Aruna D De Silva; Elizabeth J Phillips; Simon A Mallal; Ricardo da Silva Antunes; Alba Grifoni; Pandurangan Vijayanand; Daniela Weiskopf; Bjoern Peters; Alessandro Sette
Journal:  J Clin Invest       Date:  2019-03-18       Impact factor: 14.808

2.  Blood Gene Signatures of Chagas Cardiomyopathy With or Without Ventricular Dysfunction.

Authors:  Ludmila Rodrigues Pinto Ferreira; Frederico Moraes Ferreira; Helder Imoto Nakaya; Xutao Deng; Darlan da Silva Cândido; Lea Campos de Oliveira; Jean-Noel Billaud; Marion C Lanteri; Vagner Oliveira-Carvalho Rigaud; Mark Seielstad; Jorge Kalil; Fabio Fernandes; Antonio Luiz P Ribeiro; Ester Cerdeira Sabino; Edecio Cunha-Neto
Journal:  J Infect Dis       Date:  2017-02-01       Impact factor: 5.226

3.  Multiplex and genome-wide analyses reveal distinctive properties of KIR+ and CD56+ T cells in human blood.

Authors:  Wing Keung Chan; Piya Rujkijyanont; Geoffrey Neale; Jie Yang; Rafijul Bari; Neha Das Gupta; Martha Holladay; Barbara Rooney; Wing Leung
Journal:  J Immunol       Date:  2013-07-15       Impact factor: 5.422

4.  Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib.

Authors:  K Ishiyama; T Kitawaki; N Sugimoto; T Sozu; N Anzai; M Okada; M Nohgawa; K Hatanaka; N Arima; T Ishikawa; S Tabata; T Onaka; S Oka; Y Nakabo; R Amakawa; M Matsui; T Moriguchi; A Takaori-Kondo; N Kadowaki
Journal:  Leukemia       Date:  2016-06-14       Impact factor: 11.528

5.  Cytomegalovirus mediates expansion of IL-15-responsive innate-memory cells with SIV killing function.

Authors:  Gema Méndez-Lagares; Ning Chin; W L William Chang; Jaewon Lee; Míriam Rosás-Umbert; Hung T Kieu; David Merriam; Wenze Lu; Sungjin Kim; Lourdes Adamson; Christian Brander; Paul A Luciw; Peter A Barry; Dennis J Hartigan-O'Connor
Journal:  J Clin Invest       Date:  2021-08-02       Impact factor: 14.808

6.  Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.

Authors:  Amir Horowitz; Lisbeth A Guethlein; Neda Nemat-Gorgani; Paul J Norman; Sarah Cooley; Jeffrey S Miller; Peter Parham
Journal:  J Immunol       Date:  2015-09-28       Impact factor: 5.422

Review 7.  The immunogenetics of neurological disease.

Authors:  Maneesh K Misra; Vincent Damotte; Jill A Hollenbach
Journal:  Immunology       Date:  2017-12-11       Impact factor: 7.397

8.  Killer-cell immunoglobulin-like receptor expression on lymphocyte subsets in multiple sclerosis patients treated with interferon-β: evaluation as biomarkers for clinical response.

Authors:  Juan A García-León; Carlos López-Gómez; Teresa Orpez-Zafra; Virginia Reyes-Garrido; Carmen Marín-Bañasco; Begoña Oliver-Martos; Oscar Fernández; Laura Leyva
Journal:  CNS Drugs       Date:  2014-06       Impact factor: 5.749

9.  Coordinated regulation of NK receptor expression in the maturing human immune system.

Authors:  Dara M Strauss-Albee; Amir Horowitz; Peter Parham; Catherine A Blish
Journal:  J Immunol       Date:  2014-10-06       Impact factor: 5.422

10.  Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy.

Authors:  Hanna A Knaus; Sofia Berglund; Hubert Hackl; Amanda L Blackford; Joshua F Zeidner; Raúl Montiel-Esparza; Rupkatha Mukhopadhyay; Katrina Vanura; Bruce R Blazar; Judith E Karp; Leo Luznik; Ivana Gojo
Journal:  JCI Insight       Date:  2018-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.